Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4-Star Stocks Poised to Pop: GlaxoSmithKline
Motley Fool
Friday, March 5, 2010 - 10:20am
tags:
GSK
Glaxo could face $6bn Avandia liability, says UBS
Guardian, UK
Friday, March 5, 2010 - 10:14am
tags:
GSK, Avandia
House Subcommittee To Hold Drug Safety Hearing
Pharmalot
Friday, March 5, 2010 - 10:13am
tags:
drug safety
Astellas Needs to Raise OSI Bid by 15%, OrbiMed Says
Bloomberg
Friday, March 5, 2010 - 9:52am
tags:
Astellas, OSI Pharmaceuticals, M&A
Pfizer Cholesterol Failures Cleared Path for Canadian Upstart
Bloomberg
Friday, March 5, 2010 - 9:50am
tags:
Pfizer, Resverlogix, cholesterol
Uptrend in Gilead's Estimates
Yahoo/Zacks.com
Friday, March 5, 2010 - 9:48am
tags:
Gilead Sciences, GSK, Novartis
Australian court: Vioxx doubled heart attack risk
Yahoo/AP
Friday, March 5, 2010 - 9:19am
tags:
Vioxx, Australia, settlements
InterMune says FDA panel will review its lung drug
Yahoo/AP
Friday, March 5, 2010 - 8:30am
tags:
FDA, InterMune, pirfenidone
Unusual Trading in Cell Therapeutics
Seeking Alpha
Friday, March 5, 2010 - 8:29am
tags:
Cell Therapeutics
Merck sues to block generic Vytorin
Bizjournals.com
Friday, March 5, 2010 - 8:27am
tags:
generics, Merck, Vytorin, lawsuits, Teva Pharmaceuticals
CSL Rises on U.S. Approval for Immune-System Therapy Hizentra
Bloomberg
Friday, March 5, 2010 - 8:25am
tags:
CSL, FDA, Hizentra
Pfizer and Bristol-Myers say their blood thinner apixaban worked better than Lovenox in study
Yahoo/AP
Friday, March 5, 2010 - 8:24am
tags:
Pfizer, Bristol-Myers Squibb, Lovenox, Apixaban
Sanofi-Aventis Looks for More China Partnerships
Seeking Alpha
Friday, March 5, 2010 - 8:22am
tags:
China, Sanofi
Justice Department's Botox Probe Costing Allergan $100M -- And There's No End in Sight
BNET Pharma
Thursday, March 4, 2010 - 6:12pm
tags:
Botox, DOJ, Allergan
Dendreon and the Prostate Cancer Battle
Minyanville
Thursday, March 4, 2010 - 6:06pm
tags:
Dendreon, Provenge, prostate cancer
Bristol-Myers: 60 drugs in testing to boost sales
Yahoo/AP
Thursday, March 4, 2010 - 6:05pm
tags:
pipelines, Bristol-Myers Squibb
A Ray Of Hope For Medivation
Forbes
Thursday, March 4, 2010 - 6:04pm
tags:
Medivation, Pfizer, Alzheimer's disease, dimebon
FDA says Takeda has agreed to rename Kadipex to avoid confusion with other drugs
Yahoo/AP
Thursday, March 4, 2010 - 11:46am
tags:
FDA, Takeda, Kapidex
OSI Pharmaceuticals Board to Consider Astellas' Unsolicited Tender Offer
Trading Markets
Thursday, March 4, 2010 - 11:42am
tags:
Astellas, OSI Pharmaceuticals, M&A
Eisai says Aricept's U.S. sales to more than halve
Reuters
Thursday, March 4, 2010 - 11:41am
tags:
Eisai, Aricept

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.